Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
gemfibrozil lipoprotein lipase NA Successful target TTD , DGIDB Coronary Arteriosclerosis[MeSHID:D003324]
Hypertriglyceridemia[MeSHID:D015228]
Fasting[MeSHID:D005215]
Hypercholesterolemia[MeSHID:D006937]
Diet therapy[MeSHID:D004035]
Hyperlipidemia[MeSHID:D006949]
Serum[MeSHID:D044967]
Coronary heart disease[MeSHID:D003327]
Heart[MeSHID:D006321]
Heart Diseases[MeSHID:D006331]
Weight decreased[MeSHID:D015431]
Pancreatitis[MeSHID:D010195]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.29 approved unknown
gemfibrozil peroxisome proliferator-activated receptor alpha small molecule NA drugbank , DGIDB Coronary Arteriosclerosis[MeSHID:D003324]
Hypertriglyceridemia[MeSHID:D015228]
Fasting[MeSHID:D005215]
Hypercholesterolemia[MeSHID:D006937]
Diet therapy[MeSHID:D004035]
Hyperlipidemia[MeSHID:D006949]
Serum[MeSHID:D044967]
Coronary heart disease[MeSHID:D003327]
Heart[MeSHID:D006321]
Heart Diseases[MeSHID:D006331]
Weight decreased[MeSHID:D015431]
Pancreatitis[MeSHID:D010195]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.88 approved agonist
gemfibrozil solute carrier family 22 member 8 small molecule NA drugbank Coronary Arteriosclerosis[MeSHID:D003324]
Hypertriglyceridemia[MeSHID:D015228]
Fasting[MeSHID:D005215]
Hypercholesterolemia[MeSHID:D006937]
Diet therapy[MeSHID:D004035]
Hyperlipidemia[MeSHID:D006949]
Serum[MeSHID:D044967]
Coronary heart disease[MeSHID:D003327]
Heart[MeSHID:D006321]
Heart Diseases[MeSHID:D006331]
Weight decreased[MeSHID:D015431]
Pancreatitis[MeSHID:D010195]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved inhibitor
gemfibrozil solute carrier organic anion transporter family member 1b1 small molecule NA drugbank , DGIDB Coronary Arteriosclerosis[MeSHID:D003324]
Hypertriglyceridemia[MeSHID:D015228]
Fasting[MeSHID:D005215]
Hypercholesterolemia[MeSHID:D006937]
Diet therapy[MeSHID:D004035]
Hyperlipidemia[MeSHID:D006949]
Serum[MeSHID:D044967]
Coronary heart disease[MeSHID:D003327]
Heart[MeSHID:D006321]
Heart Diseases[MeSHID:D006331]
Weight decreased[MeSHID:D015431]
Pancreatitis[MeSHID:D010195]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.5 approved inhibitor
gemfibrozil solute carrier organic anion transporter family member 1b3 small molecule NA drugbank , DGIDB Coronary Arteriosclerosis[MeSHID:D003324]
Hypertriglyceridemia[MeSHID:D015228]
Fasting[MeSHID:D005215]
Hypercholesterolemia[MeSHID:D006937]
Diet therapy[MeSHID:D004035]
Hyperlipidemia[MeSHID:D006949]
Serum[MeSHID:D044967]
Coronary heart disease[MeSHID:D003327]
Heart[MeSHID:D006321]
Heart Diseases[MeSHID:D006331]
Weight decreased[MeSHID:D015431]
Pancreatitis[MeSHID:D010195]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.44 approved inhibitor
gemfibrozil solute carrier organic anion transporter family member 2b1 small molecule NA drugbank , DGIDB Coronary Arteriosclerosis[MeSHID:D003324]
Hypertriglyceridemia[MeSHID:D015228]
Fasting[MeSHID:D005215]
Hypercholesterolemia[MeSHID:D006937]
Diet therapy[MeSHID:D004035]
Hyperlipidemia[MeSHID:D006949]
Serum[MeSHID:D044967]
Coronary heart disease[MeSHID:D003327]
Heart[MeSHID:D006321]
Heart Diseases[MeSHID:D006331]
Weight decreased[MeSHID:D015431]
Pancreatitis[MeSHID:D010195]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.46 approved inhibitor
click here to return to the previous page